Real-time enrollment status for this triple negative breast cancer (tnbc) clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 12:03 AM UTC
| NCT Number | NCT07190469 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer (TNBC) |
| Phase | PHASE1 |
| Target Enrollment | 80 participants |
| Active Locations | 3 sites in the US |
| Sponsor | ProteinQure Inc. |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of September 2, 2026: Clinical trial NCT07190469 is currently recruiting participants. This phase1 study for triple negative breast cancer (tnbc) is actively seeking new participants at 3 locations across the United States. The study is sponsored by ProteinQure Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07190469 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07190469 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.